tiprankstipranks
Trending News
More News >
SynAct Pharma AB (SE:SYNACT)
:SYNACT
Sweden Market

SynAct Pharma AB (SYNACT) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
SynAct Pharma AB’s (SYNACT) Moving Averages Convergence Divergence (MACD) indicator is -0.21, suggesting SynAct Pharma AB is a Sell.
SynAct Pharma AB’s (SYNACT) 20-Day exponential moving average is 21.01, while SynAct Pharma AB’s (SYNACT) share price is kr20.55, making it a Sell.
SynAct Pharma AB’s (SYNACT) 50-Day exponential moving average is 21.19, while SynAct Pharma AB’s (SYNACT) share price is kr20.55, making it a Sell.

SynAct Pharma AB (SYNACT) Pivot Points

Dec 16, 2025, 05:03 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
18.98
19.82
20.23
21.07
21.48
22.32
22.73
Fibonacci
19.82
20.29
20.59
21.07
21.54
21.84
22.32
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

SynAct Pharma AB (SYNACT) Moving Averages

Dec 16, 2025, 05:03 AM
Period
Simple
Exponential
MA5
20.92Sell
20.80Sell
MA10
20.75Sell
20.86Sell
MA20
20.91Sell
21.01Sell
MA50
21.76Sell
21.19Sell
MA100
20.76Sell
20.66Sell
MA200
19.53Buy
19.01Buy
SynAct Pharma AB’s (SYNACT) 10-Day exponential moving average is 20.86, while SynAct Pharma AB’s (SYNACT) share price is kr20.55, making it a Sell.
SynAct Pharma AB’s (SYNACT) 100-Day exponential moving average is 20.66, while SynAct Pharma AB’s (SYNACT) share price is kr20.55, making it a Sell.
SynAct Pharma AB’s (SYNACT) stock price is kr20.55 and SynAct Pharma AB’s (SYNACT) 50-day simple moving average is 21.76, creating a Sell signal.
SynAct Pharma AB’s (SYNACT) stock price is kr20.55 and SynAct Pharma AB’s (SYNACT) 100-day simple moving average is 20.76, creating a Sell signal.
SynAct Pharma AB’s (SYNACT) stock price is kr20.55 and SynAct Pharma AB’s (SYNACT) 200-day simple moving average is 19.53, creating a Buy signal.

SynAct Pharma AB (SYNACT) Technical Indicators

Dec 16, 2025, 05:03 AM
Name
Value
Implied Action
RSI (14)
44.07
Neutral
STOCH (9,6)
48.56
Neutral
STOCHRSI (14)
36.60
Neutral
MACD (12,26)
-0.21
Sell
ADX (14)
7.15
Buy
Williams %R
-74.51
Buy
CCI (14)
-57.34
Neutral
ATR (14)
0.98
-
Ultimate Oscillator
48.80
Neutral
ROC
-1.20
Sell
SynAct Pharma AB’s (SYNACT) Relative Strength Index (RSI) is 44.07, creating a Neutral signal.
SynAct Pharma AB’s (SYNACT) Trend Strength Indicator (ADX) is 7.15, creating a Buy signal.
SynAct Pharma AB’s (SYNACT) Commodity Channel Index (CCI) is -57.34, creating a Neutral signal.
SynAct Pharma AB’s (SYNACT) Price Rate of Change (ROC) is -1.20, creating a Sell signal.

FAQ

Is SYNACT a Buy, Hold, or Sell?
Based on SYNACT’s technical indicators, SYNACT is a Sell.
    What is SYNACT’s RSI (14)?
    SYNACT’s RSI (14) is 44.07, which suggests SYNACT is a Neutral.
      What is SYNACT’s MACD?
      SYNACT’s MACD is -0.21, which suggests SYNACT is a Sell.
        What is SYNACT’s 5-day moving average?
        SYNACT’s 5-day moving average is 20.92, which suggests SYNACT is a Sell.
          What is SYNACT’s 20-day moving average?
          SYNACT 20-day moving average is 20.91, which suggests SYNACT is a Sell.
            What is SYNACT’s 50-day moving average?
            SYNACT’s 50-day moving average is 21.76, which suggests SYNACT is a Sell.
              What is SYNACT’s 200-day moving average?
              SYNACT’s 200-day moving average is 19.53, which suggests SYNACT is a Buy.
                What is SYNACT’s Williams % R (14)?
                SYNACT’s Williams % R (14) is -74.51, which suggests SYNACT is a Buy.
                  What is SYNACT’s CCI (14)?
                  SYNACT’s CCI (14) is -57.34, which suggests SYNACT is a Neutral.
                    What is the share price of SynAct Pharma AB?